Immunic presents data from phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis at actrims forum 2023
– long-term open-label treatment with vidofludimus calcium was associated with a low rate of confirmed disability worsening (cdw) over time – – cdw data compares favorably to historical trial data for currently available multiple sclerosis treatments – new york , feb. 22, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that robert j. fox, m.d., staff neurologist, mellen center for multiple sclerosis, vice-chair for research, neurologic institute, cleveland clinic, cleveland, ohio, will present data from the blinded and open-label extension (ole) parts of the company's phase 2 emphasis trial of lead asset, vidofludimus calcium (imu-838), a selective oral dhodh inhibitor, in relapsing-remitting multiple sclerosis (rrms) at the eighth annual americas committee for treatment and research in multiple sclerosis (actrims) forum 2023, taking place february 23-25 in san diego, california.
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission